In a Phase IIb trial, more patients experienced complete resolution of hives with ligelizumab compared to Xolair
Updated Date: Thu, 07 Jan 2021 00:00:00 EST
Updated Date: Thu, 07 Jan 2021 00:00:00 EST
Updated Date: Thu, 07 Jan 2021 00:00:00 EST
Updated Date: Thu, 07 Jan 2021 00:00:00 EST
Updated Date: Thu, 07 Jan 2021 00:00:00 EST
Multiple health groups in India have called for an investigation into allegations of ethical violations during a clinical […]
Coathup and colleagues’ important study shows that hospital admission rates during childhood are strongly associated with gestational age […]
People who have previously been infected with covid-19 are likely to be protected against reinfection for several months, […]